DOMINION MINERALS LIMITED (DLM)

name changed to Invert Graphite Limited

The company releases its results for its extraordinary general meeting.

The company has postponed its Extraordinary General Meeting to 20 December 2024. The meeting will discuss the company's potential acquisition of Exceptional Graphite (Aust) Pty Ltd and potential indirect acquisitions of Exceptional Graphite Resources Limited and two South Australian exploration licenses. The postponement is in accordance with Dominion's constitution.

The company lodges its Quarterly Activities Report and Cash Flow Report.

The extraordinary general meeting will be held on Monday, November 25, 2024, at 10:30am (AEDT) at Level 5, 56 Pitt Street, Sydney NSW 2000, and can be accessed online.

The company lodges its Appendix 3H.

ASX releases a notice regarding long-term suspended entities. The company's securities have been suspended for more than 3 months. If an entity does not meet the 1 or 2 year deadlines, it will be removed from the official list. The removal will usually take effect from the open of trading on the first trading day after the deadline date.

The company releases an updated notice of proposed issue of securities.

Dominion now intends (in lieu of the public offer) to conduct an offer to eligible investors of up to 116,666,667 Shares at an issue price of $0.03 per Share, to raise up to $3,500,000 (before associated costs), with a minimum subscription requirement comprising 100,000,000 of those Shares to raise $3,000,000 (before associated costs). The additional funds raised through the expanded capital raising are principally intended to be used for exploration programs at the Morogoro Project.

The company lodges its Half Year Accounts.

The company releases a notification of cessation of securities.

The Tanzanian company InVert Graphite Limited is set to acquire a 100% interest in a highly promising Tanzanian graphite project, covering approximately 386 km. The project is located near major infrastructure, with China currently dominating the market, accounting for approximately 64% of natural flake graphite supply and nearly 100% of downstream processing for battery anode material. The exploration work on the Tanzanian project has identified widespread, high-grade graphite mineralisation at the surface, with potential for a high purity graphite concentrate with high recoveries. The company plans to undertake a public equity capital raise of at least A$2 million to advance the project's development and change its name to InVert Graphite Limited. Additionally, the company has executed an agreement to indirectly acquire a 100% interest in two mineral exploration licenses in South Australia from White Hill Resources Pty Ltd. The company's securities will remain suspended until shareholder approval is obtained, the acquisition and capital raise are completed, and the company has re-complied with Chapters 1 and 2 of the ASX Listing Rules.

The company lodges its Quarterly Activities Report and Cash Flow Report.

The securities of the company have been suspended for more than three months. If an entity does not meet the 1 or 2 year deadlines, it will be removed from the official list. The removal will usually take effect from the open of trading on the first trading day after the deadline date.

The company releases the results of its meeting.

The company lodges its Quarterly Activities Report and Appendix 5B.

The company lodges its Quarterly Activities Report and Appendix 5B.

The AGM will be held on 24 May 2024, 10.00am (AEST), at Level G, 121 King William Street Adelaide SA 5000

The Company's Annual General Meeting will be held on Friday 24 May 2024. An election of directors will be held at this AGM pursuant to ASX Listing Rule 14.5. The closing date for receipt of nominations for the position of Director is Thursday, 25 April 2024. Any nominations must be received in writing no later than 5.00pm (AEST) on 25 April 2024 at the Company's registered office.

The company releases its Appendix 4G and Corporate Governance Statement.

The company lodges its Annual Report to shareholders.

The company lodges its Quarterly activities report and quarterly cashflow report.

Regarding the option to purchase the Georgia Lime Project in south west Georgia, USA held by PowerLime Inc., this was previously extended by Dominion until 31 October 2023 while the Company evaluated a decision on whether to purchase the surface and mineral rights that comprise the Project for a purchase price of US$1.5 million. Based upon evaluation of the work undertaken to date, Dominion has assessed that current market conditions for regional agricultural lime operations in the south east U.S. are generally not favourable to support development of new lime projects of the scale required to generate significant shareholder returns. The Dominion Board has resolved to let the Option lapse unexercised. Dominion Board has resolved to let the Option lapse unexercised. Dominion has been presented with a number of potential alternate business acquisition opportunities, with a focus on projects in the critical minerals sector, and is in advanced negotiations for a potential corporate acquisition.

The company lodges its Quarterly Activities Report and Quarterly Cashflow Report.

The company releases a notice of application for quotation of securities.

The following securities will be released from ASX imposed escrow at 4.00pm (AEDT) on 31 October 2023: 18,750,000 fully paid ordinary shares; and 16,187,498 unlisted options. Dominion will apply for quotation of the 18,750,000 fully paid ordinary shares on Tuesday 30 October 2023.

Dominion is not yet in a position to make an announcement in relation to the potential corporate acquisition. Dominion requests that the voluntary suspension remains in place until the Company makes an announcement to the market in relation to the corporate acquisition.

Dominion requests that the voluntary suspension remains in place until the earlier of the Company making announcement to the market in relation to the corporate acquisition or the commencement of trading on Monday 9 October 2023.

The company lodges its Half Year Accounts.

Dominion requests that the voluntary suspension remains in place until the earlier of the Company making announcement to the market in relation to the corporate acquisition or the commencement of trading on Monday 25 September 2023.

The company is providing an update on the option to purchase the Georgia Lime Project in south west Georgia USA held by the company's 100% owned U.S. subsidiarym PowerLime, Inc. The company has secured an extension to the option until 31 October 2023 in exchange for US$5,000. Dominion is in the process of assessing a potential corporate acquisition not associated wtih the Georgia Lime Project. The company's securities will remain suspended pending an announcement in relation to the alternate potential corporate acquisition.

The securities of Dominion Minerals Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of DLM, pending the release of an announcement regarding an option to acquire land on which the Georgia Lime Project is located and a potential corporation acquisition.

The suspension of trading in the securities of Dominion Minerals Limited (formerly Factor Therapeutics Limited) will be lifted from the commencement of trading on Monday, 1 November 2021 following its recompliance with Chapters 1 and 2 of the ASX Listing Rules.

The company releases the following: Appendix 1A, Information Form and Checklist, Constitution, Distribution Schedule, Information Form and Checklist Annexure 1, Powerlime Audited Accounts 31 December 2020, Powerlime Half Year Accounts 30 June 2021, Securities Trading Policy, Statement of Confirmations and Top 20 holders.

Description It is anticipated that the securities of Dominion Minerals Limited will be reinstated to quotation at 10:02:15 (+/- 15 seconds) AEDT on Monday, 1 November 2021, following its re-compliance with Chapters 1 and 2 of the ASX Listing Rules. DLM raised $4,000,000 pursuant to the offer under its replacement prospectus dated 9 September 2021 by the issue of 100,000,000 shares at an issue price of $0.04 per share.

name changed from Factor Therapeutics Limited